Potential therapeutic action of natural products from traditional Chinese medicine on Alzheimer's disease animal models targeting neurotrophic factors
Author:
- 5 August 2016
- journal article
- review article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 30 (6) , 490-501
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder in which the death of brain cells leads to memory loss and cognitive decline. To reduce the death rate and improve the biological activity of neurocytes, neurotrophic factors (NTFs) exhibit therapeutic effect on AD. However, therapeutic application of exogenous NTFs in treatment of AD is largely limited due to short half-life, poor stability, etc. Various extracts of traditional Chinese medicine (TCM) have been shown to exhibit therapeutic effects on AD, and some of these effects are associated with regulation on the expression of nerve growth factor, brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) and their associated receptors. This article reviews the progress on promotion of Panax ginseng, Rehmannia glutinosa Libosch., Epimedium, Polygala tenuifolia Willd, and seven other TCMs on secretion of NTFs during AD, with a view to preparation development and clinical application of these TCMs on AD.Keywords
Funding Information
- National Natural Science Foundation of China (31402237)
This publication has 96 references indexed in Scilit:
- Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophinsBMC Complementary and Alternative Medicine, 2014
- Panax notoginsenoside Rb1 ameliorates Alzheimer’s disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expressionExperimental and Therapeutic Medicine, 2013
- Catalpol Induces Neuroprotection and Prevents Memory Dysfunction through the Cholinergic System and BDNFEvidence-Based Complementary and Alternative Medicine, 2013
- Chotosan (Diaoteng San)-induced improvement of cognitive deficits in senescence-accelerated mouse (SAMP8) involves the amelioration of angiogenic/neurotrophic factors and neuroplasticity systems in the brainChinese Medicine, 2011
- Catalpol ameliorates beta amyloid–induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factorsNeuroscience, 2009
- Liquiritin potentiate neurite outgrowth induced by nerve growth factor in PC12 cellsCytotechnology, 2009
- Neurotrophin p75 Receptor (p75 NTR ) Promotes Endothelial Cell Apoptosis and Inhibits AngiogenesisCirculation Research, 2008
- Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairmentFree Radical Biology and Medicine, 2007
- Brain-Derived Neurotrophic Factor: A Newly Described Mediator of AngiogenesisTrends in Cardiovascular Medicine, 2007
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006